111 results on '"Meltzer, Stephen J."'
Search Results
2. Accurate Nonendoscopic Detection of Esophageal Squamous Cell Carcinoma Using Methylated DNA Biomarkers
3. EP1052: NON-ENDOSCOPIC DETECTION OF ESOPHAGEAL ADENOCARCINOMA USING METHYLATED DNA BIOMARKERS
4. Mo1170: IMPACT OF A DNA METHYLATION-BASED ASSAY ON GASTROENTEROLOGISTS’ RECOMMENDATIONS FOR ABLATION AND SURVEILLANCE TIME FOR RISK-STRATIFIED BE PATIENTS: A RANDOMIZED CLINICAL UTILITY STUDY
5. Mo1169: ANALYTICAL VALIDATION OF A DNA METHYLATION-BASED DIAGNOSTIC ASSAY FOR RISK STRATIFICATION OF PATIENTS WITH BARRETT'S ESOPHAGUS
6. Mo1150: VALIDATION OF A DNA METHYLATION-BASED DIAGNOSTIC ASSAY FOR RISK STRATIFICATION OF PATIENTS WITH BARRETT'S ESOPHAGUS.
7. Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process
8. MicroRNAs in Pathogenesis, Diagnosis, and Treatment of Gastroesophageal Cancers
9. The miR-106b-25 Polycistron, Activated by Genomic Amplification, Functions as an Oncogene by Suppressing p21 and Bim
10. Mo1126 NON-ENDOSCOPIC DETECTION OF ESOPHAGEAL ADENOCARCINOMA USING NOVEL DNA METHYLATION BIOMARKER PANEL
11. 859 ESOPREDICT: A CLINICALLY APPLICABLE PROGNOSTIC ASSAY FOR RISK STRATIFICATION OF PATIENTS WITH BARRETT'S ESOPHAGUS
12. Tu2030 – Novel Circular Rna Nf1 Acts As a Sponge, Promoting Gastric Cancer by Absorbing Mir-16
13. 371 - A Novel Non-Invasive Circulating Mirna Signature for Detection of Esophageal Adenocarcinoma
14. Long Noncoding RNAs in the Pathogenesis of Barrett’s Esophagus and Esophageal Carcinoma
15. Risk Factors for Progression of Barrett's Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma: A Large Retrospective Cohort Study
16. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease−Associated Colorectal Cancers
17. Sa1082 Comparison of Traditional Histology and Histology With Molecular Diagnostic Testing for Risk Stratification of Barrett's Esophagus: A Multi-Center Study
18. Su1050 - Risk Factors for Progression of Barrett's Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma: A Large Retrospective Cohort Study
19. Sa1820 Analytical Validation of a Novel Multi-Gene Assay for Patients With Barrett's Esophagus
20. 850d Human bile contains microRNA-laden exosomes that can be used for cholangiocarcinoma diagnosis
21. Su1964 Klotho Expression in Esophageal Squamous Cell Carcinoma and Its Association With β-Catenin and Disease Progression
22. Hypomethylation of Noncoding DNA Regions and Overexpression of the Long Noncoding RNA, AFAP1-AS1, in Barrett's Esophagus and Esophageal Adenocarcinoma
23. Comparative Evaluation of Novel Putative Stem Cell Markers and Tumor Suppressor MicroRNAs in Barrett's Esophagus
24. DNA Methylation Microarray Identifies Novel Methylation Biomarkers for Colorectal Cancer Detection
25. Barrett's Dysplasia Cancer Task Force – Bad Cat: A Global, Multidisciplinary, Consensus on the Management of High Grade Dysplasia and Early Mucosal Cancer in Barrett's Esophagus
26. M1911 Endothelin Receptor B (EDNRB) and MicroRNA-21 Expression in Gastric Cancer
27. 253 Dynamic Changes in the Expression of MicroRNA-31 During Inflammatory Bowel Disease Associated Neoplastic Transformation
28. 149 Tissue Inhibitor of Metalloproteinases 3 (TIMP3) Regulation in Cholangiocarcinoma By MicroRNA-21 and Promoter Hypermethylation
29. 1073 Micro-RNA 21 Is Overexpressed and Can Accurately Diagnose Human Cholangiocarcinoma
30. S1174 Global DNA Hypomethylation and DNA Methyltransferase-1 Downregulation in Nonneoplastic Colonic Mucosae of Ulcerative Colitis Patients
31. 184 MicroRNAs Are Differentially Expressed in Crohn's Disease
32. 1035 The Use of FISH in a Multi-Center Blinded Study to Predict Development of Neoplasia in Barrett's Esophagus
33. 197 A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
34. T1926 Comparative Tumor-Suppressive Effects of Curcumin, Resveratrol and Quercetin in Esophageal Adenocarcinoma
35. 431 A Novel MicroRNA Panel Accurately Diagnoses Cholangiocarcinoma Using Nearest Shrunken Centroids
36. M1995 InterSPORE/EDRN Barrett's Esophagus (BE) Study: Interim Report of a Multicenter Case-Control Study of Progressors to High-Grade Dysplasia/Adenocarcinoma vs. Nonprogressors
37. M2005 Down-Regulation of PTTG1 By siRNA Suppresses Tumorigenesis and Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma In Vivo
38. M1593 Setting the Stage for Inflammatory Actors: Acid-Induced NF-κB Signaling Decreases the Apoptotic Effects of TNFα in Esophageal Adenocarcinoma Cells
39. M1600 Upregulation of the Mir-25-93-106b Cluster in Barrett's-Associated Neoplastic Progression
40. M1979 Hypermethylation of the AKAP12 Promoter in Human Esophageal Cancer
41. S1204 Prediction Analysis of Microarrays to Develop An Accurate MicroRNA Panel for the Diagnosis of IBD-Neoplasia
42. Rare CpG Island Methylator Phenotype in Ulcerative Colitis–Associated Neoplasias
43. Reply
44. A Genome-Wide Search Identifies Epigenetic Silencing of Somatostatin, Tachykinin-1, and 5 Other Genes in Colon Cancer
45. Molecular Phenotype of Inflammatory Bowel Disease-Associated Neoplasms With Microsatellite Instability
46. HNPCC-associated small bowel cancer: Clinical and molecular characteristics
47. Principal components analysis exposes a genomic basis for microsatellite instability status
48. Integrated gene expression profiling and in silico epigenomic scanning to identify genes involved in microsatellite instability status of colorectal carcinoma
49. Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions
50. Tumor genomics vs. tumor genetics: A paradigm shift?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.